AVANSCURE LIFESCIENCES PVT. LTD.
Levocetirizine Pellets

Levocetirizine Pellets

Send Inquiry

Avanscure Lifesciences Pvt. Ltd., global Manufacturer of Levocetirizine DI HCL Pellets  0.5%, 10% offers for your requirements of RND / Development quantities or commercials, based on status of the product.

Levocetirizine (as levocetirizine dihydrochloride) is a third-generation non-sedative antihistamine, developed from the second-generation antihistamine cetirizine. Chemically, levocetirizine is the active enantiomer of cetirizine. It is the L-enantiomer of the cetirizine racemate.

Levocetirizine works by blocking histamine receptors. It does not prevent the actual release of histamine from mast cells, but prevents it binding to its receptors.

This in turn prevents the release of other allergy chemicals and increased blood supply to the area, and provides relief from the typical symptoms of hayfever.

The manufacturers claim it to be more effective with fewer side effects than the second-generation drugs; however, there have been no published studies supporting this assertion, although other studies have concluded it may be more effective.

Available Form:

  • Levocetirizine DI HCL Pellets
  • Levocetirizine Granules

Levocetirizine Pellets
Systematic (IUPAC) Name

Levocetirizine Pellets
Identifiers

Levocetirizine Pellets
Chemical data

2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid

CAS number

130018-77-8

Formula

C21H25ClN2O3

Mol. mass

388.888 g/mol